Vivimed Labs Limited, (BSE: 532660, NSE: VIVIMEDLAB), uses chemistry as a base to create ingredients which touch human life on daily basis. The Company manufactures active ingredients which are used in Home & Personal care segments like hair, skin, oral care and anti-microbial preservatives. The Company’s presence in manufacturing of Active Pharmaceutical Ingredients (API) , Finished Dosage Formulation (FDF) and Retail Branded Formulation caters to the inner health of people. It is also present in the Industrial care segments like photo chromic dyes and imaging chemicals. The Company has global reach with 12 manufacturing units (9 domestic and 3 overseas), 5 R&D centers (3 domestic and 2 overseas) and workforce of over 1,650 people.
The objective of Vivimed Labs Investor Relations is to ensure continuous and open communication with all financial market participants.